Global /United States /Healthcare /Medical Instruments & Supplies /STXS
chevron_leftBack

Stereotaxis, Inc.

STXS
NYSEAMERICAN: STXS Delayed
1.96USD -1.8%
As of 24 April 2025, Stereotaxis, Inc. has a market cap of $167.66M USD, ranking #18062 globally and #3041 in the United States. It ranks #1802 in the Healthcare sector, and #152 in the Medical Instruments & Supplies industry.
Global Rank
18062
Country Rank
3041
Sector Rank
1802
Industry Rank
152
Key Stats
Market Cap
$167.66MUSD
Enterprise Value
$161.45MUSD
Revenue (TTM)
$26.92MUSD
EBITDA (TTM)
-$21.52MUSD
Net Income (TTM)
-$25.35MUSD
EBITDA Margin
-80%
Profit Margin
-89%
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Instruments & Supplies
CEO
David Fischel open_in_new
Employees
139
Founded
1990
IPO
12 Aug 2004
Website
stereotaxis.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-1.8% 9.2% 1.8% -11% 0.3% -22%
Upcoming Earnings
Earnings Date
Mon, May 12
Earnings Time
bedtime After Close
EPS Estimate
-$0.0400
Revenue Estimate
$7.67M 11% yoy

Markets

Exchange Ticker Price
NYSE American
MIC: XASE
PRIMARY
STXS
Stereotaxis Inc
ISIN: US85916J4094
Shares Out.:
85.98M1 Shares Float: 70.535M2
TV:
SA:
YF:
GF:
NQ:
BA:
MS:
1.96 USD
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Stereotaxis, Inc.

Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. The company offers robotic magnetic navigation (RMN) systems, such as the Genesis RMN, which enable physicians to complete interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites; and GenesisX RMN, which is designed to enhance the accessibility of RMN by eliminating the lengthy construction cycle necessary to install prior generation RMN systems. It also offers Odyssey, a real-time information solution to manage, control, record, and share procedures across networks; and x-ray systems. In addition, the company offers disposables and other accessories, including QuikCAS, an automated catheter advancement single-use disposable device; iCONNECT; V-CAS; and MAGiC catheter for cardiac ablation procedures. Further, it provides Vdrive, a system that offers navigation and stability for the diagnostic and therapeutic devices designed to improve interventional procedures; and V-Loop, V-Sono, and V-CAS disposable components. It markets its products through direct sales force, distributors, and sales agents. Stereotaxis, Inc. was incorporated in 1990 and is based in Saint Louis, Missouri.

Similar Companies

Industry: Medical Instruments & Supplies (United States)
Name
Market Cap diff.
Intuitive Surgical, Inc.
ISRG
$174.81B
104K%
Becton, Dickinson and Co.
BDX
$58.09B
35K%
ResMed Inc.
RMD
$31.44B
19K%
The Cooper Companies, Inc.
COO
$16.17B
10K%
West Pharmaceutical Services, Inc.
WST
$15.77B
9K%
Industry: Medical Instruments & Supplies (Global)
Name
Market Cap diff.
EssilorLuxottica Société anonyme
EL
$133.72B
117.51B EUR
80K%
Alcon Inc.
ALC
$45.1B
37.42B CHF
27K%
HOYA Corp.
7741
$38.56B
5.49T JPY
23K%
Terumo Corp.
4543
$28.49B
4.08T JPY
17K%
Coloplast A/S
COLO-B
$24.61B
161.44B DKK
15K%